CONMED stock snapshot after recent trading moves

CONMED (CNMD) has seen mixed trading recently, with the stock roughly flat over the past week, a gain over the past month, and a decline across the past 3 months and the past year.

At the latest share price of $36.80, the stock has a 30 day share price return of 5.78%. However, the 1 year total shareholder return of 35.72% and 5 year total shareholder return of 73.31% point to fading momentum overall.

If you are comparing CONMED with other opportunities in healthcare technology, it could be a good time to broaden your search with 33 healthcare AI stocks.

With CONMED trading at $36.80 and indicators like a value score of 5 and an estimated intrinsic discount of about 48%, an important question is whether this represents an overlooked opportunity or whether the market is already pricing in future growth.

Most Popular Narrative: 24% Undervalued

With CONMED at $36.80 and the most followed fair value estimate at $48.40, the current price sits well below that narrative benchmark based on a 9.17% discount rate.

The accelerating adoption of minimally invasive and robotic-assisted surgeries, combined with CONMED's strong positioning via AirSeal and BioBrace (including expanding use cases and positive clinical feedback), is poised to support durable procedure volume growth and increase recurring revenue, driving sustained top-line growth.

Want to see what sits behind that growth story? The narrative leans on a specific mix of projected revenue gains, margin shifts and a tighter earnings multiple. The exact blend matters more than any single headline number.

Result: Fair Value of $48.40 (UNDERVALUED)

However, there is still real execution risk, with supply chain issues and heavy dependence on hospital capital budgets, both capable of knocking this growth story off course.

Next Steps

The mix of upside potential and flagged concerns in this article is clear, so move quickly to review the underlying data and carefully consider the 3 key rewards and 3 important warning signs.

Looking for more investment ideas?

If you stop with just one stock, you could miss opportunities that suit your goals better, so take a few minutes to scan the wider market with focused filters.

• Target potential long term compounders by checking out 51 high quality undervalued stocks that combine quality fundamentals with room for the market to reassess their prices.
• Strengthen your income stream by reviewing 13 dividend fortresses that aim to pair higher yields with resilient business models.
• Prioritize capital preservation by focusing on 71 resilient stocks with low risk scores designed to keep overall risk scores on the lower side.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.